/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

CLEARPOINT NEURO INC Share Price Today: Live Updates & Key Insights

CLEARPOINT NEURO INC share price today is $11.58, up -0.77%. The stock opened at $11.5 against the previous close of $11.62, with an intraday high of $11.88 and low of $11.5.

CLEARPOINT NEURO INC Share Price Chart

style
pb-0

CLEARPOINT NEURO INC

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

CLEARPOINT NEURO INC Share Price Performance

$11.58 -0.0077(-0.77%) CLPT at 13 Mar 2026 12:28 PM Medical Devices
Lowest Today 11.5
Highest Today 11.88
Today’s Open 11.5
Prev. Close 11.62
52 Week High 30.10
52 Week Low 8.63
Day’s Range: Low 11.5 High 11.88
52-Week Range: Low 8.63 High 30.10
1 day return -
1 Week return +15.28
1 month return -14.89
3 month return -6.93
6 month return +10.21
1 year return -8.55
3 year return +47.38
5 year return -46.45
10 year return -

CLEARPOINT NEURO INC Institutional Holdings

BlackRock Inc 6.26

Vanguard Group Inc 5.94

Vanguard Total Stock Mkt Idx Inv 2.98

Geode Capital Management, LLC 2.21

iShares Russell 2000 ETF 2.17

Rolnik Focus FIL 1.68

State Street Corp 1.62

StemPoint Capital LP 1.62

FirstWave Capital Management LLC 1.22

UBS Group AG 1.21

Brown Advisory Holdings Inc 1.11

Lane Generational LLC 1.05

Vanguard Institutional Extnd Mkt Idx Tr 1.04

Fidelity Small Cap Index 0.87

Morgan Stanley - Brokerage Accounts 0.79

Deutsche Bank AG 0.78

iShares Russell 2000 Growth ETF 0.75

Two Sigma Investments LLC 0.74

Balyasny Asset Management LLC 0.73

Northern Trust Corp 0.69

Millennium Management LLC 0.63

Vanguard Explorer Inv 0.51

Fidelity Extended Market Index 0.51

Parsons Capital Management Inc 0.49

State St Russell Sm/Mid Cp® Indx SL Cl I 0.47

Taylor Frigon Capital Management LLC 0.45

Conway Capital Management Inc 0.43

Vanguard Russell 2000 ETF 0.42

DWS Small Cap Core S 0.41

Small Cap Core Equity Composite 0.41

The Colony Group LLC 0.41

Renaissance Technologies Corp 0.40

Stt Strt® SPDR® S&P®HlthCrEqpmntETF 0.36

State St Russell Sm Cap® Indx SL Cl I 0.31

Blackrock Extended Mkt Fund CF 0.25

iShares Micro-Cap ETF 0.23

Schwab Small Cap Index 0.22

Extended Equity Market Fund K 0.21

NT R2000 Index Fund - NL 0.20

DWS Global Small Cap S 0.20

CLEARPOINT NEURO INC Market Status

Strong Buy: 2

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

CLEARPOINT NEURO INC Fundamentals

Market Cap 345.68 M

PB Ratio 21.214

PE Ratio 0.0

Enterprise Value 334.27 M

Total Assets 39.19 M

Volume 482837

CLEARPOINT NEURO INC Company Financials

Annual Revenue FY24:31390000 31.4M, FY23:22319000 22.3M, FY22:20551000 20.6M, FY21:16299000 16.3M, FY20:12829000 12.8M

Annual Profit FY24:19122000 19.1M, FY23:12967000 13.0M, FY22:13531000 13.5M, FY21:11291000 11.3M, FY20:9120000 9.1M

Annual Net worth FY24:-18914000 -18.9M, FY23:-21855000 -21.9M, FY22:-16538000 -16.5M, FY21:-15320000 -15.3M, FY20:-9108000 -9.1M

Quarterly Revenue Q3/2025:8861000 8.9M, Q2/2025:9215000 9.2M, Q1/2025:8485000 8.5M, Q3/2024:8122000 8.1M, Q2/2024:7858000 7.9M

Quarterly Profit Q3/2025:5600000 5.6M, Q2/2025:5556000 5.6M, Q1/2025:5132000 5.1M, Q3/2024:4847000 4.8M, Q2/2024:4988000 5.0M

Quarterly Net worth Q3/2025:-5891000 -5.9M, Q2/2025:-5837000 -5.8M, Q1/2025:-6026000 -6.0M, Q3/2024:-4974000 -5.0M, Q2/2024:-4408000 -4.4M

About CLEARPOINT NEURO INC & investment objective

Company Information ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Organisation Medical Devices

Employees 115

Industry Medical Devices

CEO Mr. Joseph Michael Burnett

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow